Stock Updates

How has Boston Scientific Corporation:(NYSE:BSX) performed recently?

Boston Scientific Corporation (NYSE: BSX) is a large market cap stock with a market cap of 32876.52. It is in the Medical Appliances & Equipment industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 19.46 and EPS of -0.03. At a stock price of 24.01 (-0.66%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 24.00%, more recently this last year it has grown by -98.30%. The next year growth is going to be about 13.42% and more long-term 12.92% after five years. EPS growth quarter over quarter is -303.60%. Sales growth for the past five years have been -0.90% and sales growth quarter over quarter is 15.40%.

For performance, Boston Scientific Corporation the past week has seen a gain of 0.79%. For the last month performance for Boston Scientific Corporation is 3.25%. While the last quarter is 10.97% and half year, 35.48%. Finally for the year, performance is 41.26%.

The 52-week high for Boston Scientific Corporation, is at -3.15%, and for the 52-week low it comes to a value of 69.32%. The 20-day simple moving average is 3.42% and 21.81% for the 200-day simple moving average.

Volatility for the week is at 2.47%, and for the month it is 1.70%. Boston Scientific Corporation, has a target price of 27.04.

In terms of debt, long term debt/equity is 0.83, and for total debt/equity Boston Scientific Corporation has 0.87. The gross margin is 71.40%, while operating margin is -8.00%, the profit margin is -4.50%. The current ratio is 1 and the quick ratio is 0.7.

Insider ownership is at 0.50%, with instituitional ownership at 95.10%. Boston Scientific Corporation has a payout ratio of *TBA. With the total shares outstanding coming to 1360.22. The shares float is 1345.55, with the float short at 1.73%, with short ratio coming to 2.16.

In terms of returns, the return on assets see Boston Scientific Corporation, get -1.90%, with its returns on investment at 0.70%. Return on equity is -5.40%. So will the investors see the target price of 27.04, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment